Urology · Boston, MA
NPI
1265572572
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
45 Francis St
Boston, MA, 02115
Phone (617) 732-6227
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$231K
2,374 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug William W Bassett III prescribed most often to Medicare patients was Tamsulosin Hcl, with 537 prescriptions and refills. In total William W Bassett III wrote 2,374 Medicare prescriptions that cost $231K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tamsulosin Hcl Generic | 537 | 1,379 | 156 | $7,877 |
| Finasteride Generic | 424 | 1,375 | 142 | $6,506 |
| Trospium Chloride Generic | 212 | 257 | 64 | $5,619 |
| Myrbetriq Mirabegron | 166 | 286 | 54 | $142K |
| Ciprofloxacin Hcl Generic | 116 | 116 | 99 | $838 |
| Terazosin Hcl Generic | 111 | 290 | 34 | $4,734 |
| Mirabegron Er Mirabegron | 77 | 120 | 43 | $29K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 72 | 72 | 63 | $558 |
| Oxybutynin Chloride Generic | 61 | 128 | 22 | $726 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 50 | 77 | 36 | $445 |
| Desmopressin Acetate Generic | 50 | 143 | 19 | $2,177 |
| Cephalexin Generic | 47 | 83 | 33 | $597 |
| Cefpodoxime Proxetil Generic | 42 | 49 | 27 | $1,877 |
| Silodosin Generic | 37 | 71 | 13 | $873 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 36 | 72 | Under 11 | $631 |
Brand drugs: 199 claims; generic drugs: 2,175 claims; opioid claims: 92.
Money and other things of value reported by the companies
No payments from drug or medical device companies to William W Bassett III were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.